Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion

Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials.

Detalles Bibliográficos
Autores principales: Xia, Xinyi, Li, Kening, Wu, Lingxiang, Wang, Zhihua, Zhu, Mengyan, Huang, Bin, Li, Jie, Wang, Ziyu, Wu, Wei, Wu, Min, Li, Wanlin, Li, Lu, Cai, Yun, Bosco, Bakwatanisa, Zhong, Aifang, Liu, Xiong, Lv, Tangfeng, Gan, Zhenhua, Chen, Guang, Pan, Yunhu, Liu, Caidong, Zhang, Kai, Xu, Xiaoli, Wang, Changjun, Wang, Qianghu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Letter to Blood
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414593/
https://www.ncbi.nlm.nih.gov/pubmed/32573724
http://dx.doi.org/10.1182/blood.2020007079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414593/
https://www.ncbi.nlm.nih.gov/pubmed/32573724
http://dx.doi.org/10.1182/blood.2020007079

Ejemplares similares